Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model
Tl. Frandsen et al., Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model, CANCER RES, 61(2), 2001, pp. 532-537
Several studies have indicated an interaction between tumor cells and infil
trating stromal cells regarding the urokinase plasminogen activation (uPA)
system, By developing combined uPA gene-disrupted and immunodeficient mice,
we have studied the role of stromal uPA for the growth of the MDA-MB-435 B
AG human tumor xenograft, Subcutaneous tumor growth and lung metastasis wer
e compared between wild-type immunodeficient mice and mice with the combine
d deficiencies. Tumor growth was evaluated by volume measurements and plasm
a P-galactosidase activity and metastasis was evaluated by counting lung su
rface metastases, Although no differences appeared in primary tumor take be
tween the two groups of mice, a significant difference was observed in prim
ary tumor growth, with tumors in uPA(-/-) mice growing significantly more s
lowly. In addition, a nonsignificant trend toward fewer lung metastases in
uPA(-/-) mice was observed, The present data points to a critical role of s
tromal-derived uPA in the primary tumor growth of MDA-MB-435 BAG xenografts
, whereas only a trend toward fewer lung metastases in uPA gene-disrupted m
ice was found.